Who
Jeanne Thoma
Director
Company insider
Files Form 4 as: Director, ANI Pharmaceuticals; Director, Avid Bioservices.
In numbers
- Trades disclosed
- 36
- Buys
- 2
- Sells
- 2
- Bought
- $100K
- Sold
- $2.1M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 5 Aug 2020
- Last trade
- 11 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 14 Sep 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $72K1,000 at $71.53 | filing |
| 11 Sep 2026filed 14 Sep 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $72K1,000 at $71.53 | filing |
| 21 May 2026filed 10 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,357 at $0.00 | filing |
| 21 May 2026filed 10 Jun 2026 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,357 at $0.00 | filing |
| 18 Aug 2025filed 20 Aug 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $616K6,865 at $89.76 | filing |
| 18 Aug 2025filed 20 Aug 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $1.3M14,675 at $88.87 | filing |
| 22 May 2025filed 27 May 2025 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,336 at $0.00 | filing |
| 5 Feb 2025filed 7 Feb 2025 | Avid Bioservicesoption or derivative | SEC FORM 4 Code D | —19,403 | filing |
| 5 Feb 2025filed 7 Feb 2025 | Avid Bioservicesoption or derivative | SEC FORM 4 Code D | —8,147 | filing |
| 5 Feb 2025filed 7 Feb 2025 | Avid Bioservices | SEC FORM 4 Code D | —45,611 | filing |
| 14 Dec 2024filed 17 Dec 2024 | Avid Bioservicesoption or derivative | SEC FORM 4 Code M | —26,756 at $0.00 | filing |
| 14 Dec 2024filed 17 Dec 2024 | Avid Bioservicesoption or derivative | SEC FORM 4 Code A | —8,147 at $0.00 | filing |
| 14 Dec 2024filed 17 Dec 2024 | Avid Bioservices | SEC FORM 4 Code M | —26,756 | filing |
| 21 May 2024filed 23 May 2024 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —4,410 at $0.00 | filing |
| 14 Dec 2023filed 18 Dec 2023 | Avid Bioservicesoption or derivative | SEC FORM 4 Code M | —9,612 at $0.00 | filing |
| 14 Dec 2023filed 18 Dec 2023 | Avid Bioservicesoption or derivative | SEC FORM 4 Code A | —26,756 at $0.00 | filing |
| 14 Dec 2023filed 18 Dec 2023 | Avid Bioservices | SEC FORM 4 Code M | —9,612 | filing |
| 3 Dec 2023filed 5 Dec 2023 | Avid Bioservicesoption or derivative | SEC FORM 4 Code M | —1,537 at $0.00 | filing |
| 3 Dec 2023filed 5 Dec 2023 | Avid Bioservices | SEC FORM 4 Code M | —1,537 | filing |
| 23 May 2023filed 24 May 2023 | ANIP ANI PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,865 at $0.00 | filing |
News
ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ETANIP · manilatimes.net · 23 Oct 2026
0 headlines in the last 90 days name Jeanne Thoma; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.